Asia Pacific Pcr Multiplex Assays Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
USD
1.21 Million
USD
2.42 Million
2024
2032
 Período de previsão |
2025 –2032 |
 Tamanho do mercado (ano base ) | USD 1.21 Million |
 Tamanho do mercado ( Ano de previsão) | USD 2.42 Million |
 CAGR |
% |
| Principais participantes do mercado |
|
Asia-Pacific Polymerase Chain Reaction (PCR) Multiplex Assays Market Segmentation, By Products and Services (Reagents and Consumables, Instruments and Accessories, Software and Services), Applications (Clinical Diagnostics, Research and Development), End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes, Others) – Industry Trends and Forecast to 2032
Asia-Pacific Polymerase Chain Reaction (PCR) Multiplex Assays Market Analysis
A multiplex assay can amplify more than one target sequence by using numerous primer pairs in reaction mixes. The PCR technique saves time and effort in laboratory investigations, making it a useful and quick screening tool for clinical and research labs. Manufacturers of PCR multiplex assays are looking to expand their business and provide new services.
Polymerase Chain Reaction (PCR) Multiplex Assays Market Size
Asia-Pacific Polymerase Chain Reaction (PCR) Multiplex Assays market size was valued at USD 1.21 million in 2024 and is projected to reach USD 2.42 million by 2032, with a CAGR of 9.1% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Polymerase Chain Reaction (PCR) Multiplex Assays Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel |
|
Key Market Players |
Hologic, Inc. (U.S), Luminex (U.S), BD (U.S), Abbott (U.S), Thermo Fisher Scientific Inc. (U.S), QIAGEN (Germany), Agilent Technologies Inc. (U.S), MESO SCALE DIAGNOSTICS, LLC (U.S), Randox Laboratories Ltd. (U.K), Seegene Inc. (Korea), Illumina, Inc (U.S), Bio-Rad Laboratories, Inc. (U.S), Quest Diagnostics Incorporated (U.S), Abcam Plc (U.K) |
|
Market Opportunities |
|
Polymerase Chain Reaction (PCR) Multiplex Assays Market Definition
Multiplex assays are a new technology that allows you to run multiple target sequences in a single step. The evolution of PCR multiplex assays in terms of smart features such as voice command, facial authentication, and radio-frequency identification (RFID) features has shifted the system from a manual instrument to an automated PCR multiplexes system.
Polymerase Chain Reaction (PCR) Multiplex Assays Market Dynamics
Drivers
- Growing number of hospitals across emerging economies
Healthcare technological breakthroughs, a growing research and development industry, expanding healthcare reforms, and a rising need for healthcare infrastructure will likely propel the regional market forward.
- Growing incidences of chronic illness
Multiplex assays in companion diagnostics are becoming more popular due to the rising prevalence of cancer. Additionally, the advantages of multiplex assays over singleplex and traditional assays, technological advancements, rising healthcare expenditure, and rising awareness about the multifactorial nature of various diseases and pathological conditions are expected to drive the Multiplex Assays market forward.
Opportunities
Expanded government financing, increasing pharmaceutical and biotechnology research activities, and a greater focus on improving experiment efficiency will propel the business forward. Because of the growing recognition of the multifactorial character of illnesses and pathological situations like cancer and Alzheimer's disease, a cost-effective and time-saving technique for evaluating many analyzers in a single sample is needed.
Restraints/Challenges
High equipment prices and a scarcity of experienced workers could stymie the expansion of the multiplex assays business in the near future.
This Polymerase Chain Reaction (PCR) multiplex assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the PCR multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Polymerase Chain Reaction (PCR) Multiplex Assays Market Scope
The Polymerase Chain Reaction (PCR) multiplex assays market is segmented on the basis of type, product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Reagents and Consumables
- Instruments and Accessories
- Software and Services
Type
- Protein Based Multiplex Assays
- Nucleic Acid-Based Multiplex Assay
- Others
End-User
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Clinical Laboratories
- Hospitals
Application
- Research and Development
- Clinical Diagnostics
- Companion Diagnostics
Polymerase Chain Reaction (PCR) Multiplex Assays Market Regional Analysis
The Polymerase Chain Reaction (PCR) multiplex assays market is analyzed and market size insights and trends are provided by country, type, product, application and end user as referenced above.
The countries covered in the Polymerase Chain Reaction (PCR) multiplex assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The rising usage of multiplex assay, North America is likely to maintain its market share dominance over the forecast period. Other reasons, such as the improvement of technology, the presence of well-developed healthcare infrastructures, and the increased prevalence of various chronic diseases, are expected to boost the multiplex assay market in this area.
Due to the increased usage of companion diagnostics, Asia Pacific is predicted to develop at a rapid pace, with an increasing market share throughout the forecast period. Furthermore, the multiplex assay market in this area is predicted to rise due to rising acceptance of advanced technologies, skyrocketing need for safe and effective treatment choices, and new product launches.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Polymerase Chain Reaction (PCR) Multiplex Assays Market Share
The Polymerase Chain Reaction (PCR) multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Polymerase Chain Reaction (PCR) multiplex assays market.
Polymerase Chain Reaction (PCR) Multiplex Assays Market Leaders Operating in the Market Are:
- Hologic, Inc. (U.S)
- Luminex (U.S)
- BD (U.S)
- Abbott (U.S)
- Thermo Fisher Scientific Inc. (U.S)
- QIAGEN (Germany)
- Agilent Technologies Inc. (U.S)
- MESO SCALE DIAGNOSTICS, LLC (U.S)
- Randox Laboratories Ltd. (U.K)
- Seegene Inc. (Korea)
- Illumina, Inc (U.S)
- Bio-Rad Laboratories, Inc. (U.S)
- Quest Diagnostics Incorporated (U.S)
- Abcam Plc (U.K)
Latest Developments in Polymerase Chain Reaction (PCR) Multiplex Assays Market
- Olink announced in December 2018 that oncology's 92-plex protein biomarker panel is now accessible as kits or as an analysis service. In two specialized panels, this novel biomarker panel can test 184 proteins. This novel assays panel covers a wide range of oncology-related diseases and biological processes.
- PerkinElmer, Inc. announced in October 2014 that they would be exhibiting Omics Office software in London; it is new and revolutionary software for qPCR and digital PCR Congress. This new programme assists scientists in importing, analysing, and validating complex data in order to make informed conclusions. This software can help you visualise and analyse biological data at a high level of sophistication. The company's product portfolio has been expanded in the market as a result of the debut of this product.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
